Ruth Devenyns

Ruth Devenyns

Ruth Devenyns

Chief Executive Officer - Precirix

Ms. Devenyns has over 25 years of experience in the financial industry in both investment banking and venture capital in the healthcare sector. Prior to joining Precirix as CEO in 2017, she was CFO of Ogeda, a Belgium-based clinical-stage drug discovery company, until their acquisition by Astellas Pharma Inc.

Ms. Devenyns has a master’s in applied economics from the University of Ghent.

Join us in person on 19 May

Flanders.bio Strategic Partners

Flanders.bio Supporting Partners